贝瑞基因：股东高扬所持1%公司股份将被司法强制执行

Core Viewpoint - The major shareholder Gao Yang of Berry Genomics (000710.SZ) is facing judicial enforcement for the forced liquidation of 3,535,214 shares, representing 1% of the company's total equity, due to a breach of contract in a stock pledge repurchase agreement [1] Group 1 - The forced liquidation is a result of Gao Yang's default on a stock pledge repurchase business [1] - The court ruling was made by the Chengdu Financial Court [1] - The company states that this event will not have a significant adverse impact on its production, operations, or financial status [1] Group 2 - The forced sale will not significantly affect the company's governance structure [1]